V2 WINE GROUP AND DRY CREEK VINEYARD EXTEND THEIR SALES AND MARKETING AGREEMENT
Jul 07, 2016 08:12 am UTC| Business
SONOMA, Calif., July 7, 2016 -- V2 Wine Group of Sonoma, California and Dry Creek Vineyard of Healdsburg, California are proud to announce the extension of their agreement between the two companies. Under the terms of the...
Stolt-Nielsen Limited Reports Unaudited Results For the Second Quarter of 2016
Jul 07, 2016 06:25 am UTC| Business
LONDON, July 7, 2016 -- Stolt-Nielsen Limited (Oslo Brs: SNI) today reported unaudited results for the second quarter ended May 31, 2016. Net profit attributable to shareholders in the second quarter was $37.8 million,...
Jul 07, 2016 06:09 am UTC| Business
OXFORDSHIRE, United Kingdom, July 7, 2016 -- Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialising and developing products in oncology, immunology and...
Jul 07, 2016 05:11 am UTC| Business
ACR20, ACR50 and ACR70 scores of up to 81%, 49% and 24% respectively at week 12 Very encouraging efficacy data compared to tocilizumab with up to 41% of patients in clinical remission at week 12 Favourable safety...
WILLIAM J. ARNONE NAMED CHIEF EXECUTIVE OFFICER OF NATIONAL ACADEMY OF SOCIAL INSURANCE
Jul 06, 2016 20:57 pm UTC| Business
WASHINGTON, July 6, 2016 -- The National Academy of Social Insurance announced that William J. Arnone has been selectedas Chief Executive Officer, beginning July 1, 2016. As one of the nation's leading experts on...
California Community Foundation Awards $9.3 Million to Strengthen Los Angeles County
Jul 06, 2016 19:09 pm UTC| Business
LOS ANGELES, July 6, 2016 -- The California Community Foundation (CCF) has awarded $9,393,600 through 112 grants to Los Angeles County nonprofit organizations working to address the needs of our region. This quarter's...
Nanobiotix reports successful results from Phase I/II Trial of NBTXR3 in Head & Neck Cancer
Jul 06, 2016 17:22 pm UTC| Business
Primary safety and feasibility endpoints achieved Preliminary positive signs of antitumoral effect in all evaluable patients Company preparing now registration clinical plan, including EU and USA PARIS and...